| Early CAG group (N = 1148) | Deferred CAG/no CAG group (N = 1227) | p-value |
---|---|---|---|
Targeted temperature management | 670/849 (78.9) | 570/709 (80.4) | 0.47 |
Hypotension | 244/554 (44.0) | 293/692 (42.3) | 0.55 |
Use of inotropic or vasopressors | 319/512 (62.3) | 422/688 (61.3) | 0.73 |
Use of intra-aortic balloon pump | 96/993 (9.7) | 40/1026 (3.9) |  < 0.001 |
Heart failure < 45% | 200/496 (40.3) | 134/313 (42.8) | 0.48 |
Need for renal replacement therapy | 34/839 (4.1) | 42/701 (6.0) | 0.08 |
Major bleedinga | 15/347 (4.3) | 23/357 (6.4) | 0.21 |
CAG performed | 1148 (100.0) | 600/1227 (48.9) |  < 0.001 |
PCI performed | 205/248 (82.7) | 129/356 (36.2) |  < 0.001 |
CABG | 8/292 (2.7) | 9/392 (2.3) | 0.71 |
Laboratory values | |||
 Lowest pH | 7.2 [7.1–7.3] | 7.2 [7.0–7.3] | 0.003 |
 Peak lactate, mmol/L | 5.5 [3.4–9.1] | 6.0 [3.4–9.5] | 0.38 |
 Peak CRP, mg/L | 105 [30–201] | 122 [61–200] | 0.06 |
 Peak leukocytes, ·109/L | 18.4 [14.3–24.2] | 17.6 [13.9–23.2] | 0.34 |
 Peak CK, U/L | 1604 [629–4421] | 828 [296–2411] | < 0.001 |
 Survival at hospital discharge | 544/765 (71.1) | 596/850 (70.1) | 0.66 |